RXRX
NASDAQStockRecursion Pharmaceuticals, Inc.
$3.40+0.11 (+3.34%)
52-Week Range
$3.29
$6.84
Key Stats
Market Cap
1.5B
P/E Ratio
—
Dividend Yield
—
Beta
0.96
Volume
12.4M
Avg Volume
16.7M
Performance
1M
-8.10%
3M
-21.67%
6M
-31.03%
YTD
-21.67%
1Y
-48.19%
3Y
-56.02%
5Y
-89.49%
Price Chart
ETF Exposure
RXRX is held by 118 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| ARKG | ARK Genomic Revolution ETF | 3.83% |
| MOON | Direxion Moonshot Innovators ETF | 1.69% |
| HEAL | Global X - HealthTech ETF | 1.52% |
| ROBT | First Trust Nasdaq Artificial Intelligence and Robotics ETF | 1.22% |
| ARKK | ARK Innovation ETF | 1.22% |
| NIFE | Direxion Fallen Knives ETF | 1.05% |
| WISE | Themes Generative Artificial Intelligence ETF | 0.78% |
| CURE.AX | Global X - S&P Biotech ETF | 0.70% |
| XBI | State Street SPDR S&P Biotech ETF | 0.69% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.59% |
| WDNA.L | WisdomTree BioRevolution UCITS ETF - USD Acc | 0.39% |
| WDNA | WisdomTree BioRevolution Fund | 0.36% |
| HELX | Franklin Genomic Advancements ETF | 0.28% |
| AGIQ | SoFi Agentic AI ETF | 0.26% |
| PWS | Pacer WealthShield ETF | 0.19% |
| XDAT | Franklin Exponential Data ETF | 0.18% |
| NUSC | Nuveen ESG Small-Cap | 0.18% |
| DRDR.L | iShares Healthcare Innovation UCITS ETF | 0.17% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 0.17% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.15% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.14% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.13% |
| 2B77.DE | iShares Ageing Population UCITS ETF | 0.13% |
| IBB | iShares Biotechnology ETF | 0.13% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.10% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.09% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.09% |
| IWO | iShares Russell 2000 Growth ETF | 0.09% |
| STXK | Strive Small-Cap ETF | 0.07% |
| KOMP | State Street SPDR S&P Kensho New Economies Composite ETF | 0.07% |
| BKSE | BNY Mellon US Small Cap Core Equity ETF | 0.07% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 0.06% |
| VBK | Vanguard Small-Cap Growth ETF | 0.06% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 0.05% |
| VTWO | Vanguard Russell 2000 ETF | 0.05% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.05% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.04% |
| IWM | iShares Russell 2000 ETF | 0.04% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.04% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.04% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.04% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.04% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.04% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.04% |
| RSSL | Global X - Russell 2000 ETF | 0.04% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.04% |
| UWM | ProShares - Ultra Russell2000 | 0.03% |
| VB | Vanguard Small-Cap ETF | 0.03% |
| VXF | Vanguard Extended Market ETF | 0.03% |
| URTY | ProShares - UltraPro Russell2000 | 0.03% |
Page 1 of 3Next
About RXRX ETF Exposure
Recursion Pharmaceuticals, Inc. (RXRX) is held by 118 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.5B, RXRX is a widely held institutional stock. The stock currently trades at $3.40. Investors can gain exposure to RXRX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RXRX, sorted by portfolio weight.